RT Journal Article
SR Electronic
T1 Utility of the 3-minute chair rise test (3CRT) to assess cardiopulmonary fitness of patients with non-small cell lung cancer before lung resection
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 1724
DO 10.1183/13993003.congress-2020.1724
VO 56
IS suppl 64
A1 Mathilde Azzi
A1 David Debeaumont
A1 Tristan Bonnevie
A1 Bernard Aguilaniu
A1 Damiano Cerasuolo
A1 Fairuz Boujibar
A1 Antoine Cuvelier
A1 Francis-Edouard Gravier
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/1724.abstract
AB Objectives: Peak oxygen consumption (V̇O2peak) measured by incremental cardiopulmonary exercise testing (CPET) is considered as the gold-standard method for predicting surgical risk in patients with non-small cell lung cancer (NSCLC). Practical difficulties in performing CPET have led to development of field tests. This study aimed to determine the relation between the performance at the 3-minute chair rise test (3CRT), a field test requiring only minimal space and resources, and the V̇O2peak measured during CPET.Methods: Data from 36 patients with NSCLC were retrospectively analysed. Relationship between V̇O2peak and performance at the 3CRT was assessed using a Pearson’s correlation test. In addition, sensitivity-specificity analysis was carried out to estimate a threshold 3CRT value for the prediction of V̇O2peak ≥15 ml/kg/min.Results: A significant correlation between the V̇O2peak and the number of chair rises was found (r2=0.37, p<0.01). A performance of 49 chair rises or more predicted a V̇O2peak ≥15 ml/kg/min with a sensitivity of 0.75 and a specificity of 0.81.Conclusions: The 3CRT could help to screen NSCLC patients with impaired cardiopulmonary fitness, who need further physiologic assessement by CPET and specific prehabilitation programs before lung resection. Prospective studies with larger sample sizes are needed to validate these results.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 1724.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).